Research & Innovation
How a heart medication could unlock a new targeted approach in lymphoma
Feb 4, 2026Researchers at VCU Massey Comprehensive Cancer Center discovered an innovative way to use a drug already approved in treating irregular heartbeat to selectively target specific functions of enzymes in lymphoma, effectively killing cancer cells and reducing tumor growth with little toxicity. ...